Hair loss in women
Female hair loss behaves differently from male pattern loss, and the difference decides whether surgery is even on the table. For most women it is not — and that is the honest answer rather than a discouraging one.
Diffuse, not receding
Male pattern loss recedes from defined places, leaving a stable donor band behind. Female pattern loss is typically diffuse: thinning spread across the top of the scalp with the frontal hairline often preserved, which is why it is usually described using the Ludwig scale rather than the Norwood one.
That pattern creates the central problem. If thinning is diffuse, the donor zone at the back and sides is frequently thinning too — and moving unstable hair into a thinning area produces a result that fades. Commonly cited figures put the share of women who are good surgical candidates at around two to five percent.
So the assessment is the whole conversation. It is not a formality on the way to booking surgery.

Genuine surgical indications
Traction alopecia
Years of tension from braids, weaves or extensions, where the surrounding donor hair is healthy and stable.
Defined pattern loss
Thinning limited to specific areas with a demonstrably stable donor zone.
Hairline lowering
Reducing a naturally high forehead — an aesthetic rather than a pathological indication.
Scar camouflage
Placing hair into scars from facelift surgery, trauma or burns.
Bloodwork before surgery
Iron deficiency, thyroid disease, hormonal conditions including PCOS, postpartum shedding and a long list of medications all cause hair loss in women. Every one of those is better addressed medically than surgically, and several will keep undermining a transplant if left uncorrected.
Telogen effluvium — diffuse shedding two to three months after a stressor — is also common and usually self-limiting. Operating on it treats something that was going to recover.
Questions
Sources: American Hair Loss Association · American Academy of Dermatology · NIH / PubMed Central
Related
Start with what is causing it.
For most women the productive first step is diagnosis, not a graft count.
